A recent paper shows that bioinformatic analysis identifies that PLA2G4A has physical interactions with several oncogenic proteins (such as RUVBL2, CAP1, STAT3, and MYCBP) in AML, resulting in multiple effects on the malignant phenotype of AML cells (41). This evidence concerns the gene CAP1 and acute myeloid leukemia.